Chemed Corporation(CHE) Stock Research - Grey Stern Research

Chemed Corporation (CHE) Stock Analysis

$551.14 (-1.44%)

CHE Financial Performance


Use the table below to view Chemed Corporation's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2024

Metric Value Ranking among Peers
Price $551.14 -
52 Week Low $512.12 -
52 Week High $654.62 -
Market Cap $8.3 Billion 3/11
Gross Margin 40% 5/11
Profit Margin 13% 1/11
EBITDA margin 11% 5/11
Q3 - 2024 Revenue $606.2 Million 7/11
Q3 - 2024 Earnings $75.8 Million 4/11
Q3 - 2024 Free Cash Flow $77.0 Million 4/11
Trailing 4 Quarters Revenue $2.4 Billion 7/11
Trailing 4 Quarters Earnings $301.7 Million 3/11
Quarterly Earnings Growth 1% 10/11
Annual Earnings Growth 28% 6/11
Quarterly Revenue Growth 7% 8/11
Annual Revenue Growth 7% 8/11
Cash On Hand $238.5 Million 2/11
Short Term Debt $42.5 Million 6/11
Long Term Debt $105.4 Million 8/11

Chemed Corporation Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Chemed Corporation's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 27.37 4/11
PS 3.47 1/11
PB 6.68 1/11
PC 34.63 5/11
Liabilities to Equity 0.43 10/11
ROA 0.17 1/11
ROE 0.24 1/11
Current Ratio 3.32 2/11
Quick Ratio 0.45 2/11
Long Term Debt to Equity 0.09 8/11
Debt to Equity 0.12 8/11
Burn Rate -3.91 8/11
Cash to Cap 0.03 7/11
CCR 1.02 6/11
EV to EBITDA 121.22 3/11
EV to Revenue 3.44 1/11

Company Details

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CEO: Mr. Kevin McNamara

Website: https://www.chemed.com

Address: 255 E 5th St Ste 2600 Cincinnati, OHIO

Exchange: New York Stock Exchange

Industry: Medical Care Facilities

Chemed Corporation Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Chemed Corporation. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Healthcare Services Group, Inc. HCSG $837.7 Million
Universal Health Services, Inc. UHS $11.0 Billion
Acadia Healthcare Company, Inc. ACHC $4.1 Billion
Surgery Partners, Inc. SGRY $2.6 Billion
Select Medical Holdings Corporation SEM $2.5 Billion
Encompass Health Corporation EHC $9.5 Billion
Addus HomeCare Corporation ADUS $2.4 Billion
The Ensign Group, Inc. ENSG $7.8 Billion
The Pennant Group, Inc. PNTG $943.6 Million
InnovAge Holding Corp. INNV $501.2 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
CHE Income Statements
Quarter Year Revenue Earnings
Q3 2024 $ 606.2 Million $75.8 Million
Q2 2024 $ 595.9 Million $70.9 Million
Q1 2024 $ 589.2 Million $65.0 Million
Q4 2023 $ 585.9 Million $90.1 Million
Q3 2023 $ 564.5 Million $75.0 Million
Q2 2023 $ 553.8 Million $53.4 Million
Q1 2023 $ 560.2 Million $54.1 Million
Q4 2022 $ 546.7 Million $62.1 Million

View All

CHE Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2024 $238.5 Million $1.8 Billion $147.9 Million $1.2 Billion
Q2 2024 $222.9 Million $1.7 Billion $146.4 Million $1.2 Billion
Q1 2024 $313.4 Million $1.7 Billion $159.7 Million $1.2 Billion
Q4 2023 $264.0 Million $1.8 Billion $155.1 Million $1.1 Billion
Q3 2023 $173.2 Million $1.6 Billion $137.0 Million $1.0 Billion
Q2 2023 $159.9 Million $1.5 Billion $140.9 Million $952.1 Million
Q1 2023 $58.1 Million $1.4 Billion $165.8 Million $880.1 Million
Q4 2022 $74.1 Million $1.4 Billion $247.0 Million $798.7 Million

View All

CHE Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 $77.0 Million -$13.5 Million $15.5 Million
Q2 2024 $66.5 Million -$11.1 Million -$90.4 Million
Q1 2024 $72.4 Million -$12.2 Million $49.4 Million
Q4 2023 $96.8 Million -$11.8 Million $90.8 Million
Q3 2023 $17.3 Million -$11.7 Million $13.2 Million
Q2 2023 $115.9 Million -$16.4 Million $101.9 Million
Q1 2023 $43.5 Million -$17.0 Million -$16.1 Million
Q4 2022 $81.9 Million -$18.3 Million $66.3 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions